mRNA肿瘤疫苗五年数据印证疗效 云顶新耀抢跑国内个性化肿瘤疫苗赛道

e公司
Jan 21

1月20日,默沙东与莫德纳联合披露的mRNA肿瘤疫苗mRNA-4157(intismeran autogene)联合K药的二期临床五年随访数据,为全球肿瘤免疫治疗领域注入“强心剂”。受消息影响,莫德纳当天股价上涨2.8%,随着mRNA产品临床推进,其股价重拾升势,最新价已逼近近一年高点。这项代号为KEYNOTE-942/mRNA-4157-P201的研究显示,在完全切除后的高危III/IV期...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10